NCT07308665 is a clinical trial of Aquacel Ribbon in Ulcer Foot, sponsored by ConvaTec Inc..

Who is sponsoring NCT07308665?

NCT07308665 is sponsored by ConvaTec Inc..

What drugs are being tested in NCT07308665?

Interventions in NCT07308665: Aquacel Ribbon.

What condition does NCT07308665 study?

NCT07308665 studies Ulcer Foot, Ulcer Healing, Wound Infection.

Is NCT07308665 still recruiting?

NCT07308665 is currently completed. Last updated 30 December 2025.

Last reviewed 2025-12-30 · How we verify

NCT07308665

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Aquacel With Strengthening Fiber (WSF) Ribbon Dressings

Completed Last updated 30 December 2025

What this trial tests

trial testing Aquacel Ribbon in Ulcer Foot in 214 participants. Completed in 17 September 2025.

Timeline

1 January 2017

Primary endpoint
8 April 2025

17 September 2025

Quick facts

Lead sponsor	ConvaTec Inc.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	214
Start date	1 January 2017
Primary completion	8 April 2025
Estimated completion	17 September 2025

Drugs / interventions tested

Aquacel Ribbon

Conditions studied

Ulcer Foot — all drugs for Ulcer Foot →
Ulcer Healing — all drugs for Ulcer Healing →
Wound Infection — all drugs for Wound Infection →

Sponsor

ConvaTec Inc.

Who can join

Eligibility, any sex, with Ulcer Foot or Ulcer Healing. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Retrospective, multi-site, non-comparative, post-market study

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Ulcer Foot

Currently open trials in the same condition.

NCT07391319 — The Prospective, Double-blind, Multicenter, Placebo-controlled, Randomized, Comparative Clinical Trial · Phase 3 · recruiting
NCT06124586 — Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS) · NA · recruiting
NCT04210089 — Total Contact Soft Cast in Diabetic Foot Ulcers · NA · recruiting

Other ConvaTec Inc. trials

Trials by the same sponsor.

NCT07342049 — ConvaVAC™ Ag+ Negative Pressure Wound Therapy System in Chronic Wounds · NA · not yet recruiting
NCT07209358 — EDX110 Randomized Control Trial for Treatment of DFUs · NA · recruiting
NCT07308678 — AQUACEL® Ag+ Extra™ vs Cutimed® Sorbact® · completed
NCT06614491 — SCOPE - Single-Point Classification Observational Peristomal Evaluation · completed
NCT07170566 — A Retrospective, Observational Study of the Real-world Safety and Performance of InnovaMatrix® AC at a Single Centre · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07308665 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by ConvaTec Inc.
Last refreshed: 30 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07308665.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing